Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

ALNY Insider Trading (Alnylam Pharmaceuticals)

Insider Ownership Percentage: 1.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $29,394,580.17

Alnylam Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Alnylam Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alnylam Pharmaceuticals Share Price & Price History

Current Price: $148.25
Price Change: Price Increase of +2.4 (1.65%)
As of 07/1/2022 04:59 PM ET

This chart shows the closing price history over time for ALNY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Being A Successful Trader Just Got Easier…
From 10x Trading Champion Chuck Hughes comes the e-book helping thousands to survive the bear market, “Options trading Made Easy”!

Already full of tools and strategies for success, each copy now comes with a daily Trade of the Day, straight from Chuck to you!

Download your copy now!
>>>

Alnylam Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2022Steven M. PaulDirectorSell15,000$170.69$2,560,350.001,000View SEC Filing Icon  
12/23/2021Akshay VaishnawInsiderSell2,879$190.93$549,687.47View SEC Filing Icon  
11/12/2021John MaraganoreCEOSell33,978$171.52$5,827,906.56View SEC Filing Icon  
8/13/2021John MaraganoreCEOSell33,979$199.78$6,788,324.62248,744View SEC Filing Icon  
8/6/2021Yvonne GreenstreetCOOSell53,064$199.00$10,559,736.00View SEC Filing Icon  
8/5/2021Laurie KeatingEVPSell10,000$188.95$1,889,500.0013,008View SEC Filing Icon  
7/12/2021Laurie KeatingEVPSell6,812$178.96$1,219,075.526,944View SEC Filing Icon  
6/18/2021Akshay VaishnawInsiderSell14,708$175.00$2,573,900.0024,953View SEC Filing Icon  
6/9/2021Laurie KeatingEVPSell1,734$154.00$267,036.005,132View SEC Filing Icon  
5/13/2021John MaraganoreCEOSell33,979$130.78$4,443,773.62248,744View SEC Filing Icon  
4/21/2021Akshay VaishnawInsiderSell2,732$136.95$374,147.4022,908View SEC Filing Icon  
4/19/2021Akshay VaishnawInsiderSell3,706$137.67$510,205.0222,908View SEC Filing Icon  
1/12/2021Laurie KeatingEVPSell14,941$160.20$2,393,548.202,234View SEC Filing Icon  
1/12/2021Yvonne GreenstreetCOOSell3,125$161.00$503,125.007,945View SEC Filing Icon  
12/18/2020Steven M. PaulDirectorSell15,000$140.00$2,100,000.0016,000View SEC Filing Icon  
11/25/2020Phillip A. SharpDirectorSell30,000$124.89$3,746,700.00265,633View SEC Filing Icon  
9/29/2020Akshay VaishnawInsiderSell971$140.00$135,940.0015,090View SEC Filing Icon  
9/9/2020Barry E GreenePresidentSell44,530$123.23$5,487,431.9065,412View SEC Filing Icon  
8/20/2020John MaraganoreCEOSell34,765$136.13$4,732,559.45
7/13/2020Laurie KeatingEVPSell47,250$160.67$7,591,657.5016,433View SEC Filing Icon  
7/9/2020Yvonne GreenstreetCOOSell11,236$161.00$1,808,996.0015,759View SEC Filing Icon  
7/7/2020Barry E GreenePresidentSell22,265$159.99$3,562,177.3584,501View SEC Filing Icon  
5/20/2020John MaraganoreCEOSell34,765$143.22$4,979,043.30232,354View SEC Filing Icon  
5/6/2020Barry E GreenePresidentSell22,265$149.99$3,339,527.3584,501View SEC Filing Icon  
5/5/2020Yvonne GreenstreetCOOSell7,811$140.00$1,093,540.0011,070View SEC Filing Icon  
4/20/2020Akshay VaishnawInsiderSell21,971$140.00$3,075,940.0035,119View SEC Filing Icon  
4/20/2020Laurie KeatingEVPSell10,000$139.00$1,390,000.0024,492View SEC Filing Icon  
2/20/2020John MaraganoreCEOSell34,765$131.85$4,583,765.25224,758View SEC Filing Icon  
2/10/2020Steven M. PaulDirectorSell30,000$130.00$3,900,000.0031,000View SEC Filing Icon  
2/10/2020Yvonne GreenstreetCOOSell9,892$130.00$1,285,960.0012,458View SEC Filing Icon  
2/7/2020Akshay VaishnawInsiderSell23,708$125.00$2,963,500.0030,923View SEC Filing Icon  
2/7/2020Yvonne GreenstreetCOOSell6,250$123.90$774,375.0012,458View SEC Filing Icon  
1/29/2020Laurie KeatingEVPSell6,337$119.00$754,103.0014,932View SEC Filing Icon  
1/27/2020Laurie KeatingEVPSell41,037$117.70$4,830,054.9024,632View SEC Filing Icon  
11/20/2019Marsha FanucciDirectorSell75,000$100.00$7,500,000.0030,000View SEC Filing Icon  
11/20/2019Yvonne GreenstreetCOOSell8,404$105.00$882,420.004,070View SEC Filing Icon  
11/18/2019Phillip A. SharpDirectorSell15,000$91.71$1,375,650.00250,633View SEC Filing Icon  
10/22/2019Barry E GreenePresidentSell58,913$89.99$5,301,580.87111,851View SEC Filing Icon  
10/14/2019John MaraganoreCEOSell49,456$79.45$3,929,279.20239,449View SEC Filing Icon  
See Full Table
Trading With A Small Account?
If you’ve been told it’s not doable, you’ve been lied to! Hi, I’m pro-trader Chuck Hughes and I grew my once tiny investment into an empire!

If you want to do the same–or simply want to feel more secure in your finances–”Options Trading Made Easy” is the guide you need.

Get a copy here!
>>>

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.39% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALNY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alnylam Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/30/2022Amalgamated Bank13,355$2.18M0.0%+27.5%0.011%Search for SEC Filing on Google Icon
6/7/2022Teachers Retirement System of The State of Kentucky66,123$10.80M0.1%+13.8%0.055%Search for SEC Filing on Google Icon
6/2/2022Mirae Asset Global Investments Co. Ltd.65,572$10.71M0.0%-12.8%0.054%Search for SEC Filing on Google Icon
5/23/2022Neuberger Berman Group LLC6,285$1.03M0.0%+69.8%0.005%Search for SEC Filing on Google Icon
5/20/2022International Biotechnology Trust PLC38,000$21.71M4.9%-70.3%0.031%Search for SEC Filing on Google Icon
5/20/2022The Manufacturers Life Insurance Company 1,997,762$326.98M0.3%+17.3%1.654%Search for SEC Filing on Google Icon
5/20/2022Toroso Investments LLC2,403$0.39M0.0%+10.2%0.002%Search for SEC Filing on Google Icon
5/19/2022Capital World Investors5,999,674$979.69M0.2%+1,781.1%4.966%Search for SEC Filing on Google Icon
5/19/2022Capital International Sarl13,315$2.17M0.1%N/A0.011%Search for SEC Filing on Google Icon
5/19/2022Capital International Ltd. CA21,839$3.57M0.2%N/A0.018%Search for SEC Filing on Google Icon
5/19/2022Capital Group International Inc. CA 19,390$3.17M0.0%N/A0.016%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA66,700$10.89M0.0%+1.0%0.055%Search for SEC Filing on Google Icon
5/17/2022Wealthfront Advisers LLC12,845$2.10M0.0%+873.8%0.011%Search for SEC Filing on Google Icon
5/17/2022Virtu Financial LLC3,862$0.63M0.0%-53.5%0.003%Search for SEC Filing on Google Icon
5/17/2022Advisors Asset Management Inc.3,936$0.64M0.0%+8.0%0.003%Search for SEC Filing on Google Icon
5/17/2022Meiji Yasuda Asset Management Co Ltd.1,250$0.20M0.0%-10.7%0.001%Search for SEC Filing on Google Icon
5/17/2022Beacon Pointe Advisors LLC1,740$0.28M0.0%+29.4%0.001%Search for SEC Filing on Google Icon
5/17/2022Polar Capital Holdings Plc229,833$37.53M0.2%-57.1%0.190%Search for SEC Filing on Google Icon
5/17/2022Prosight Management LP22,704$3.71M2.4%-28.8%0.019%Search for SEC Filing on Google Icon
5/17/2022Quantbot Technologies LP3,806$0.62M0.1%N/A0.003%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada22,595$3.69M0.0%-19.9%0.019%Search for SEC Filing on Google Icon
5/17/2022RTW Investments LP1,683,362$274.88M5.7%-14.8%1.393%Search for SEC Filing on Google Icon
5/17/2022Eaton Vance Management306,228$50.01M0.1%+606.7%0.253%Search for SEC Filing on Google Icon
5/17/2022Endurant Capital Management LP10,379$1.70M0.4%N/A0.009%Search for SEC Filing on Google Icon
5/17/2022Ensign Peak Advisors Inc36,430$5.95M0.0%-10.6%0.030%Search for SEC Filing on Google Icon
5/17/2022Farallon Capital Management LLC1,023,873$167.19M0.9%-14.0%0.848%Search for SEC Filing on Google Icon
5/17/2022Gilder Gagnon Howe & Co. LLC791,224$129.20M1.2%-5.8%0.655%Search for SEC Filing on Google Icon
5/17/2022Guggenheim Capital LLC25,744$4.20M0.0%-2.1%0.021%Search for SEC Filing on Google Icon
5/17/20221832 Asset Management L.P.545$88K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System199,213$32.53M0.0%-5.0%0.165%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.681,553$111.29M0.0%-0.7%0.564%Search for SEC Filing on Google Icon
5/16/2022Captrust Financial Advisors1,232$0.20M0.0%+36.4%0.001%Search for SEC Filing on Google Icon
5/16/2022Allstate Corp8,077$1.32M0.0%-25.6%0.007%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP7,034,487$1.15B0.2%+2.8%5.823%Search for SEC Filing on Google Icon
5/16/2022Deep Track Capital LP463,663$75.71M4.9%-4,062.9%0.384%Search for SEC Filing on Google Icon
5/16/2022State Street Corp2,909,490$475.09M0.0%+2.1%2.408%Search for SEC Filing on Google Icon
5/16/2022Echo Street Capital Management LLC2,101$0.34M0.0%-46.6%0.002%Search for SEC Filing on Google Icon
5/16/2022Eversept Partners LP52,871$8.63M0.7%-24.7%0.044%Search for SEC Filing on Google Icon
5/16/2022Vident Investment Advisory LLC12,161$1.98M0.1%+73.1%0.010%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.968,755$158.19M0.0%+8.8%0.802%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG27,976$4.57M0.0%-68.7%0.023%Search for SEC Filing on Google Icon
5/16/2022Hsbc Holdings PLC47,827$7.82M0.0%+15.7%0.040%Search for SEC Filing on Google Icon
5/13/2022Rhenman & Partners Asset Management AB130,000$21.23M2.1%-25.7%0.108%Search for SEC Filing on Google Icon
5/13/2022Bellevue Group AG1,229,563$200.78M2.3%-7.9%1.018%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp763,340$124.65M0.0%-0.8%0.632%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.372,623$60.85M0.0%+2.7%0.308%Search for SEC Filing on Google Icon
5/13/2022Edgestream Partners L.P.4,002$0.65M0.1%-81.8%0.003%Search for SEC Filing on Google Icon
5/13/2022Lazard Asset Management LLC1,065$0.17M0.0%+47.3%0.001%Search for SEC Filing on Google Icon
5/13/2022Utah Retirement Systems21,372$3.49M0.0%-0.5%0.018%Search for SEC Filing on Google Icon
5/13/2022Rosenblum Silverman Sutton S F Inc CA41,761$6.82M1.7%-1.4%0.035%Search for SEC Filing on Google Icon
5/13/2022DCF Advisers LLC19,000$3.10M1.4%+5.6%0.016%Search for SEC Filing on Google Icon
5/13/2022First Trust Advisors LP402,652$65.75M0.1%-20.6%0.333%Search for SEC Filing on Google Icon
5/13/2022XTX Topco Ltd1,497$0.24M0.1%N/A0.001%Search for SEC Filing on Google Icon
5/13/2022Royal London Asset Management Ltd.41,560$6.79M0.0%+3.1%0.034%Search for SEC Filing on Google Icon
5/13/2022USS Investment Management Ltd79,962$13.06M0.1%+5.6%0.066%Search for SEC Filing on Google Icon
5/13/2022Pearl River Capital LLC2,875$0.47M0.1%-41.3%0.002%Search for SEC Filing on Google Icon
5/13/2022Parkman Healthcare Partners LLC54,008$8.82M2.6%-6.4%0.045%Search for SEC Filing on Google Icon
5/13/2022Tekla Capital Management LLC158,606$25.90M0.9%-16.4%0.131%Search for SEC Filing on Google Icon
5/13/2022Mackenzie Financial Corp19,376$3.16M0.0%+11.3%0.016%Search for SEC Filing on Google Icon
5/13/2022Loomis Sayles & Co. L P868,748$141.86M0.2%-12.8%0.719%Search for SEC Filing on Google Icon
5/13/2022Baird Financial Group Inc.1,379$0.23M0.0%+15.5%0.001%Search for SEC Filing on Google Icon
5/13/2022Candriam Luxembourg S.C.A.303,653$49.58M0.3%+26.2%0.251%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.10,829,144$1.77B0.0%+1.2%8.964%Search for SEC Filing on Google Icon
5/13/2022National Pension Service180,898$29.54M0.1%+2.9%0.150%Search for SEC Filing on Google Icon
5/13/2022Prudential PLC1,781$0.29M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/13/2022Allianz Asset Management GmbH44,928$7.34M0.0%-12.0%0.037%Search for SEC Filing on Google Icon
5/13/2022Canada Pension Plan Investment Board1,013$0.17M0.0%-98.2%0.001%Search for SEC Filing on Google Icon
5/13/2022Aviva PLC73,040$11.93M0.1%+91.1%0.060%Search for SEC Filing on Google Icon
5/13/2022Sei Investments Co.28,442$4.59M0.0%+11.8%0.024%Search for SEC Filing on Google Icon
5/13/2022Vontobel Holding Ltd.6,446$1.07M0.0%-10.9%0.005%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP181,271$29.60M0.0%+1.2%0.150%Search for SEC Filing on Google Icon
5/12/2022BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp18,462$3.02M0.0%-11.9%0.015%Search for SEC Filing on Google Icon
5/12/2022Westwood Holdings Group Inc.16,380$2.67M0.0%-9.3%0.014%Search for SEC Filing on Google Icon
5/12/2022Great West Life Assurance Co. Can62,369$10.79M0.0%+21.2%0.052%Search for SEC Filing on Google Icon
5/12/2022APG Asset Management N.V.7,097$1.04M0.0%-21.1%0.006%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.7,608,954$1.24B0.0%-0.8%6.298%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers115,877$18.92M0.0%-3.3%0.096%Search for SEC Filing on Google Icon
5/12/2022Panagora Asset Management Inc.6,565$1.07M0.0%+96.4%0.005%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC7,763$1.27M0.0%N/A0.006%Search for SEC Filing on Google Icon
5/12/2022VELA Investment Management LLC2,975$0.49M0.3%+22.4%0.002%Search for SEC Filing on Google Icon
5/12/2022Aureus Asset Management LLC2,563$0.42M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/12/2022D.A. Davidson & CO.3,981$0.65M0.0%-5.9%0.003%Search for SEC Filing on Google Icon
5/12/2022Bank of Montreal Can73,751$12.43M0.0%+86.8%0.061%Search for SEC Filing on Google Icon
5/12/2022Natixis Advisors L.P.10,359$1.69M0.0%-17.3%0.009%Search for SEC Filing on Google Icon
5/12/2022E Fund Management Co. Ltd.1,732$0.28M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/12/2022Eagle Asset Management Inc.255,937$41.79M0.2%+0.2%0.212%Search for SEC Filing on Google Icon
5/12/2022AlphaCrest Capital Management LLC3,763$0.61M0.0%+34.9%0.003%Search for SEC Filing on Google Icon
5/12/2022Eagle Health Investments LP131,244$21.43M5.3%+15.4%0.109%Search for SEC Filing on Google Icon
5/12/2022Harvest Fund Management Co. Ltd342$55K0.0%-60.9%0.000%Search for SEC Filing on Google Icon
5/12/2022Mitsubishi UFJ Trust & Banking Corp468,452$76.49M0.2%-0.5%0.388%Search for SEC Filing on Google Icon
5/12/2022Private Advisor Group LLC3,472$0.57M0.0%-9.2%0.003%Search for SEC Filing on Google Icon
5/12/2022Cetera Advisor Networks LLC4,299$0.70M0.0%+44.0%0.004%Search for SEC Filing on Google Icon
5/12/2022Oppenheimer & Co. Inc.5,012$0.82M0.0%+76.3%0.004%Search for SEC Filing on Google Icon
5/12/2022HighTower Advisors LLC134,689$21.99M0.0%+3.9%0.111%Search for SEC Filing on Google Icon
5/12/2022Blueshift Asset Management LLC5,506$0.90M0.1%-3.4%0.005%Search for SEC Filing on Google Icon
5/11/2022US Bancorp DE10,278$1.68M0.0%+7.1%0.009%Search for SEC Filing on Google Icon
5/11/2022American Century Companies Inc.1,131,844$184.82M0.1%+12.9%0.937%Search for SEC Filing on Google Icon
5/11/2022Seven Eight Capital LP1,764$0.29M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/11/2022Astrantus Ltd1,900$0.31M0.5%-44.4%0.002%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp638,868$104.32M0.0%+6.1%0.529%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; ALN-AAT02 for the treatment of AAT deficiency-associated liver disease; ALN-HBV02 to treat chronic HBV infection; Zilebesiran to treat hypertension; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia and rare bleeding disorders, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1 and recurrent renal stones, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Read More on Alnylam Pharmaceuticals

Today's Range

Now: $148.25
Low: $144.67
High: $148.40

50 Day Range

MA: $135.19
Low: $120.42
High: $162.07

52 Week Range

Now: $148.25
Low: $117.58
High: $212.00

Volume

29,478 shs

Average Volume

852,649 shs

Market Capitalization

$17.91 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top insider investors include:
  1. Phillip A Sharp (Director)
  2. John Maraganore (CEO)
  3. Barry E Greene (President)
  4. Akshay Vaishnaw (Insider)
  5. Laurie Keating (EVP)
  6. Steven M Paul (Director)
  7. Yvonne Greenstreet (COO)
  8. Jeffrey W Dunn (CEO)
Learn More about top insider investors at Alnylam Pharmaceuticals.
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.